Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

463 companies

Ticker ▾	Company	Revenue	Net income	Net margin	Return on equity	Revenue growth	Diluted EPS
AYTU	Aytu Biopharma, Inc Manufacturing · Year ended 2026-06-30 · USD	$57.57M	-$14.25M	-24.8%	-40.4%	-13.3%	n/a
AXSM	Axsome Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$638.50M	-$183.17M	-28.7%	-207.5%	65.5%	-$3.68
AVTX	Avalo Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$59.0K	-$78.26M	n/m	-94.2%	-86.6%	-$5.84
AVIR	Atea Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$158.35M	n/a	-57.5%	n/a	-$1.94
AVBP	ArriVent BioPharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$166.31M	n/a	-54.1%	n/a	-$4.32
AUPH	Aurinia Pharmaceuticals Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	$287.20M	n/a	49.4%	n/a	$2.07
ATXI	Avenue Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.40M	-$2.91M	-207.2%	-158.8%	n/a	n/a
ATOS	Atossa Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$34.77M	n/a	-88.4%	n/a	-$4.04
ATNM	Actinium Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$90.0K	-$33.89M	n/m	-432.6%	n/a	-$1.09
ASMB	Assembly Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$72.30M	-$6.12M	-8.5%	-3.0%	153.5%	-$0.55
ASBP	Aspire Biopharma Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	$6.2K	-$24.48M	n/m	n/a	n/a	-$16.38
ARWR	Arrowhead Pharmaceuticals, Inc. Manufacturing · Year ended 2025-09-30 · USD	$829.45M	$30.11M	3.6%	6.0%	n/m	-$0.01
ARVN	Arvinas, Inc. Manufacturing · Year ended 2025-12-31 · USD	$262.60M	-$80.80M	-30.8%	-18.6%	-0.3%	-$1.14
ARTL	Artelo Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$12.88M	n/a	n/a	n/a	-$12.52
ARQT	Arcutis Biotherapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$372.07M	-$16.14M	-4.3%	-8.5%	123.4%	-$0.13
ARDX	Ardelyx, Inc. Manufacturing · Year ended 2025-12-31 · USD	$407.32M	-$61.60M	-15.1%	-36.9%	22.1%	-$0.26
ARCT	Arcturus Therapeutics Holdings Inc. Manufacturing · Year ended 2025-12-31 · USD	$82.03M	-$65.78M	-80.2%	-30.7%	-46.1%	-$2.40
AQST	Aquestive Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$44.55M	-$83.78M	-188.1%	n/a	-22.6%	-$0.78
APVO	Aptevo Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$25.97M	n/a	-149.4%	n/a	-$87.27
APUS	Apimeds Pharmaceuticals US, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$6.00M	n/a	-3.9%	n/a	-$0.55
APRE	Aprea Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$12.60M	n/a	-101.3%	n/a	-$1.93
ANVS	Annovis Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$28.85M	n/a	-171.2%	n/a	-$1.40
ANTX	AN2 Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$35.17M	n/a	-66.3%	n/a	-$1.16
ANRO	Alto Neuroscience, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$63.24M	n/a	-41.8%	n/a	-$2.19
ANNX	Annexon, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$206.69M	n/a	-97.7%	n/a	-$1.34

Rows per page: 2550 100